Edition:
United States

Dicerna Pharmaceuticals Inc (DRNA.OQ)

DRNA.OQ on NASDAQ Stock Exchange Global Select Market

12.74USD
7 Dec 2018
Change (% chg)

-- (--)
Prev Close
$12.74
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
190,120
52-wk High
$17.96
52-wk Low
$6.81

Chart for

About

Dicerna Pharmaceuticals, Inc. is a ribonucleic acid (RNA) interference-based biopharmaceutical company. The Company operates in the segment of discovery, research and development of treatments based on its RNA interference (RNAi) technology platform. The Company is focused on the discovery and development of treatments for rare... (more)

Overall

Beta: 2.31
Market Cap(Mil.): $906.48
Shares Outstanding(Mil.): 62.73
Dividend: --
Yield (%): --

Financials

  DRNA.OQ Industry Sector
P/E (TTM): -- 95.96 30.88
EPS (TTM): -2.23 -- --
ROI: -75.10 0.60 13.80
ROE: -121.95 -2.18 15.29

Eli Lilly makes bet on gene-silencing drug firm Dicerna

Eli Lilly and Co is spending $100 million for a stake in Dicerna Pharmaceuticals Inc as part of a licensing deal, making it the latest major drugmaker to bet on gene-silencing technology.

Oct 29 2018

Eli Lilly makes bet on gene-silencing drug firm Dicerna

* Lilly to pay Dicerna $100 mln upfront plus $100 mln for stake

Oct 29 2018

Earnings vs. Estimates